NASDAQ:SIBN
SI-BONE Inc. Stock News
$14.51
+0.250 (+1.75%)
At Close: May 01, 2024
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Monday, 29'th Apr 2024
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
09:00am, Monday, 29'th Apr 2024
SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
04:09pm, Monday, 15'th Apr 2024
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
04:09pm, Monday, 04'th Mar 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:05am, Monday, 19'th Feb 2024
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
04:09pm, Monday, 05'th Feb 2024
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Wednesday, 31'st Jan 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Sizing Up SI-BONE After Q3 Earnings
12:47pm, Thursday, 16'th Nov 2023
Today, we take a look at SI-BONE, Inc., a medical device company focused on developing implantable devices for musculoskeletal disorders. The company is targeting a large potential market, delivers co
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
04:09pm, Tuesday, 14'th Nov 2023
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript
09:22pm, Monday, 06'th Nov 2023
SI-BONE, Inc. (NASDAQ:SIBN ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Saqib Iqbal - Senior Director of IR Laura Francis - CEO Anshul Maheshwari - CFO Conferenc
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
04:09pm, Wednesday, 01'st Nov 2023
SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
04:09pm, Monday, 16'th Oct 2023
SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
Si-Bone (SIBN) Upgraded to Buy: Here's Why
01:32pm, Monday, 09'th Oct 2023
Si-Bone (SIBN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?
11:17am, Friday, 08'th Sep 2023
Here is how Si-Bone (SIBN) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.
SI-BONE: Another Record Quarter, Reinvesting For Future Growth, Reiterate Buy
04:28pm, Thursday, 31'st Aug 2023
SI-BONE, Inc. presents compelling long-term value with robust growth in unit economics, high gross profits, and attractive valuation upside. Q2 FY'23 showed record-breaking sales of $33.3 million, wit
